160 related articles for article (PubMed ID: 31600200)
1. LRRC33 is a novel binding and potential regulating protein of TGF-β1 function in human acute myeloid leukemia cells.
Ma W; Qin Y; Chapuy B; Lu C
PLoS One; 2019; 14(10):e0213482. PubMed ID: 31600200
[TBL] [Abstract][Full Text] [Related]
2. Specificity of TGF-β1 signal designated by LRRC33 and integrin α
Duan Z; Lin X; Wang L; Zhen Q; Jiang Y; Chen C; Yang J; Lee CH; Qin Y; Li Y; Zhao B; Wang J; Zhang Z
Nat Commun; 2022 Aug; 13(1):4988. PubMed ID: 36008481
[TBL] [Abstract][Full Text] [Related]
3. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
[TBL] [Abstract][Full Text] [Related]
4. BATF promotes extramedullary infiltration through TGF-β1/Smad/MMPs axis in acute myeloid leukemia.
Zhang R; Miao J; Zhai M; Liu R; Li F; Xu X; Huang L; Wang T; Yang R; Yang R; Wang Y; He A; Wang J
Mol Carcinog; 2024 Jun; 63(6):1146-1159. PubMed ID: 38477642
[TBL] [Abstract][Full Text] [Related]
5. Latency-associated peptide of transforming growth factor-β1 is not subject to physiological mannose phosphorylation.
Barnes J; Warejcka D; Simpliciano J; Twining S; Steet R
J Biol Chem; 2012 Mar; 287(10):7526-34. PubMed ID: 22262853
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow stromal cells induce an ALDH+ stem cell-like phenotype and enhance therapy resistance in AML through a TGF-β-p38-ALDH2 pathway.
Yuan B; El Dana F; Ly S; Yan Y; Ruvolo V; Shpall EJ; Konopleva M; Andreeff M; Battula VL
PLoS One; 2020; 15(11):e0242809. PubMed ID: 33253299
[TBL] [Abstract][Full Text] [Related]
7. Latent transforming growth factor-beta complex in Chinese hamster ovary cells contains the multifunctional cysteine-rich fibroblast growth factor receptor, also termed E-selectin-ligand or MG-160.
Olofsson A; Hellman U; Ten Dijke P; Grimsby S; Ichijo H; Morén A; Miyazono K; Heldin CH
Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):427-34. PubMed ID: 9182700
[TBL] [Abstract][Full Text] [Related]
8. Perturbation of transforming growth factor (TGF)-beta1 association with latent TGF-beta binding protein yields inflammation and tumors.
Yoshinaga K; Obata H; Jurukovski V; Mazzieri R; Chen Y; Zilberberg L; Huso D; Melamed J; Prijatelj P; Todorovic V; Dabovic B; Rifkin DB
Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18758-63. PubMed ID: 19022904
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone stimulation and PKA signaling of latent transforming growth factor-beta binding protein-1 (LTBP-1) mRNA expression in osteoblastic cells.
Kwok S; Qin L; Partridge NC; Selvamurugan N
J Cell Biochem; 2005 Aug; 95(5):1002-11. PubMed ID: 15880704
[TBL] [Abstract][Full Text] [Related]
10. Activation of latent transforming growth factor-β1, a conserved function for pregnancy-specific beta 1-glycoproteins.
Warren J; Im M; Ballesteros A; Ha C; Moore T; Lambert F; Lucas S; Hinz B; Dveksler G
Mol Hum Reprod; 2018 Dec; 24(12):602-612. PubMed ID: 30371828
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation of integrin β6 transcription induced by TGF-β1 in human oral squamous cell carcinoma cells.
Xu M; Yin L; Cai Y; Hu Q; Huang J; Ji Q; Hu Y; Huang W; Liu F; Shi S; Deng X
J Cell Biochem; 2018 May; 119(5):4193-4204. PubMed ID: 29274289
[TBL] [Abstract][Full Text] [Related]
12. Megakaryocyte-derived excessive transforming growth factor β1 inhibits proliferation of normal hematopoietic stem cells in acute myeloid leukemia.
Gong Y; Zhao M; Yang W; Gao A; Yin X; Hu L; Wang X; Xu J; Hao S; Cheng T; Cheng H
Exp Hematol; 2018 Apr; 60():40-46.e2. PubMed ID: 29307605
[TBL] [Abstract][Full Text] [Related]
13. Latent TGF-β binding proteins (LTBPs) 1 and 3 differentially regulate transforming growth factor-β activity in malignant mesothelioma.
Vehviläinen P; Koli K; Myllärniemi M; Lindholm P; Soini Y; Salmenkivi K; Kinnula VL; Keski-Oja J
Hum Pathol; 2011 Feb; 42(2):269-78. PubMed ID: 21106222
[TBL] [Abstract][Full Text] [Related]
14. Bi-allelic LoF NRROS Variants Impairing Active TGF-β1 Delivery Cause a Severe Infantile-Onset Neurodegenerative Condition with Intracranial Calcification.
Dong X; Tan NB; Howell KB; Barresi S; Freeman JL; Vecchio D; Piccione M; Radio FC; Calame D; Zong S; Eggers S; Scheffer IE; Tan TY; Van Bergen NJ; Tartaglia M; Christodoulou J; White SM
Am J Hum Genet; 2020 Apr; 106(4):559-569. PubMed ID: 32197075
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma.
Ananth S; Knebelmann B; Grüning W; Dhanabal M; Walz G; Stillman IE; Sukhatme VP
Cancer Res; 1999 May; 59(9):2210-6. PubMed ID: 10232610
[TBL] [Abstract][Full Text] [Related]
16. Abnormal expression of TGF-beta type II receptor isoforms contributes to acute myeloid leukemia.
Wu Y; Su M; Zhang S; Cheng Y; Liao XY; Lin BY; Chen YZ
Oncotarget; 2017 Feb; 8(6):10037-10049. PubMed ID: 28052022
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of transforming growth factor-β1 suppress Pokemon/epithelial-mesenchymal transition expression in human bladder cancer cells.
Li W; Kidiyoor A; Hu Y; Guo C; Liu M; Yao X; Zhang Y; Peng B; Zheng J
Tumour Biol; 2015 Feb; 36(2):1155-62. PubMed ID: 25722217
[TBL] [Abstract][Full Text] [Related]
18. Identification of the thiol isomerase-binding peptide, mastoparan, as a novel inhibitor of shear-induced transforming growth factor β1 (TGF-β1) activation.
Brophy TM; Coller BS; Ahamed J
J Biol Chem; 2013 Apr; 288(15):10628-39. PubMed ID: 23463512
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
[TBL] [Abstract][Full Text] [Related]
20. Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome.
Schlötzer-Schrehardt U; Zenkel M; Küchle M; Sakai LY; Naumann GO
Exp Eye Res; 2001 Dec; 73(6):765-80. PubMed ID: 11846508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
